DAVI · Davion Healthcare PLC · Documents
Market Cap
$150.00M
Shares
25.00M
Volume · Oct 23
479.47K
Avg daily vol (2 sessions)
518.94K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | Davion Healthcare Plc’s shares are expected to begin trading on Nasdaq Global Market on Thursday 22 October 2026 under “DAVI.” Glenn Williams becomes Chief Executive Officer, Jeremy North Chief Operating Officer, and Jack Kaye Chairman. | 2026-10-20 | — | |
| 6-K | — | 2026-09-15 | — | |
| 20-F/A | — | 2026-05-06 | 2025-12-31 | |
| 20-F | — | 2026-04-30 | 2025-12-31 | |
| 6-K | — | 2026-01-05 | — | |
| F-1/A | — | 2025-12-05 | — | |
| 6-K | — | 2025-12-02 | — | |
| F-1/A | — | 2025-11-07 | — | |
| F-1/A | — | 2025-09-26 | — | |
| F-1 | — | 2025-08-04 | — |
Showing 1–10 of 10 filings